Protocol for the validation of microbiological control of cellular products according to German regulators recommendations – Boon and Bane for the manufacturer

Publisher： John Wiley & Sons Inc

E-ISSN： 1423-0410|108|3|314-317

ISSN： 0042-9007

Source： VOX SANGUINIS, Vol.108, Iss.3, 2015-04, pp. : 314-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanoparticle aerosols: boon or bane for breathing?

By Banerjee Rinti  

Nanomedicine, Vol. 7, Iss. 6, 2012-06 ,pp. : 795-798

Future Medicine

Access to resources Recommend Favorite

Requirements for the admission of medical products made of NiTinol according to the German Medical Products Act (MPG)

By Frey-Köppel A.  

Minimally Invasive Therapy and Allied Technologies, Vol. 13, Iss. 4, 2004-08 ,pp. : 222-227

Informa Healthcare

Access to resources Recommend Favorite

Clarification: CMS Will Accept Alternatives to Manufacturer's Maintenance Recommendations

By  

JCAH Perspectives, Vol. 30, Iss. 12, 2010-12 ,pp. : 6-6

Joint Commission Resources

Access to resources Recommend Favorite

The use of smartphones in general and internal medicine units: A boon or a bane to the promotion of interprofessional collaboration?

By Lo Vivian   Wu Robert C.   Morra Dante   Lee Lydia   Reeves Scott  

Journal of Interprofessional Care, Vol. 26, Iss. 4, 2012-07 ,pp. : 276-282

Informa Healthcare

Access to resources Recommend Favorite

Invariant Natural Killer T Cells: Boon or Bane in Immunity to Intracellular Bacterial Infections?

By  

Journal of Innate Immunity, Vol. 6, Iss. 5, 2014-06 ,pp. : 575-584

Karger

Access to resources Recommend Favorite